Matthew D. Hellmann MD

Matthew Hellmann is a medical oncologist who specializes in the care of patients with lung cancers, particularly non-small-cell lung cancers. He is dedicated to identifying better treatments for people with all stages of the disease and to providing compassionate care for patients and their families. His research focuses on developing innovative and effective ways to harness the body’s immune system to fight cancer. He is a member of the Immunotherapeutics Group, where we design and lead early-phase clinical trials of immunotherapies for patients with a variety of different cancers.